Resistance of ER-positive breast cancer to tamoxifen therapy may be driven by APOBEC3B

Denosumab improves disease-free survival for postmenopausal patients with HR-positive breast cancer

Test to identity which breast cancer patients will respond to platinum-based chemotherapy

Women with luminal A breast cancer subtype do not seem to benefit from adjuvant chemotherapy

Denosumab improves disease-free survival for postmenopausal HR-positive breast cancer

Women with luminal A subtype of breast cancer did not benefit from adjuvant chemotherapy

Pathologic complete response to presurgery chemo improves survival for triple-negative breast cancer

Telepathology in Tanzania

PCA3 test for prostate cancer in Africa

Telepathology in Malawi

Assessing the best screening methods for HPV/cervical cancer in Africa

Chemoprevention in breast cancer and possible vaccine for prostate cancer